ArticlePloS one2022

Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo.

Allison A Fuchs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.